stem cells

Huge Hack at UCLA Health: Millions of Patients’ Personal & Medical Data Compromised

ucla_healthsystem

On May 5 UCLA Health System determined that its computer systems had suffered a massive hack. The cyber attack compromised the data of millions of UCLA patients according to the University: “the attacker had accessed parts of the UCLA Health network that contain personal information, like name, address, date of birth, social security number, medical

Huge Hack at UCLA Health: Millions of Patients’ Personal & Medical Data Compromised Read More »

Recap of BEINGS 2015 Meeting by Aaron Levine: Shaping Future of Cellular Biotech

aaron-levine_rob-felt_hires

Last week I attended Biotech & the Ethical Imagination (BEINGS 2015), the summit I previewed on this blog back in early May. It many ways the summit lived up to its lofty ambitions. Steven Pinker kicked off the event by emphasizing the power and importance of biomedical research, noting that almost everyone is affected by

Recap of BEINGS 2015 Meeting by Aaron Levine: Shaping Future of Cellular Biotech Read More »

Stem cells on Mother’s Day, clinical trials, and more

stem-cell-clinical-trials-map

One of the many interesting ways in which “stem cells” are named in different languages around the world is “mother cells”. For example, in Spanish, you can learn more about these “mother cells” here in ¿Qué son las células madre? On Mother’s Day it is worth thinking about where the stem cell field stands at this

Stem cells on Mother’s Day, clinical trials, and more Read More »

Risks for Healthy PBSC Donors? One Family’s Powerful Experience

stem cell donor, where do stem cells come from?

By Jane Langille A few weeks ago, I wrote to Dr. Paul Knoepfler after reading his book Stem Cells: An Insider’s Guide because I was intrigued by his stem cell theory of aging. I wondered if his theory might mean that someone who mobilized and donated hematopoietic cells might be shortening their own lifetime supply. After

Risks for Healthy PBSC Donors? One Family’s Powerful Experience Read More »

New biotech Semma Therapeutics stem cell diabetes arena

Semma_05-4065

A new biotech startup, Semma Therapeutics, announced that it seeks to fight diabetes via translating technology from the lab of Doug Melton at Harvard to the clinic. Update: Note that the firm was recently acquired by Vertex. Another major player in cell therapy-based arena for Diabetes is most likely good news for patients. Quoted in the Boston

New biotech Semma Therapeutics stem cell diabetes arena Read More »

Subscribe to Our Newsletter

Be the first to know about the latest developments in stem cell and regenerative medicine research.